APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy

作者: Jeffrey B. Kopp , Jurgen Heymann , Cheryl A. Winkler

DOI: 10.1016/J.SEMNEPHROL.2017.07.004

关键词:

摘要: Apolipoprotein L1 (APOL1) genetic variants are potent risk factors for glomerular disease, but one or more additional required expression of disease. Uncontrolled poorly controlled human immunodeficiency virus (HIV) infection is the most susceptibility factor APOL1 nephropathy that has been identified to date. associated with HIV-associated (HIVAN), a podocyte not HIV-immune complex primarily disease mesangium. The mechanism by which HIV brings out latent remains be defined. There at least two classes candidate mechanisms explain interaction between HIV-1 and APOL1. First, variant proteins accessory implicated in HIVAN may target same related intracellular pathways podocytes. Recent data suggest roles interleukin 1b transcription EB. Second, features uncontrolled infection, including increased circulating such as interferon, drive gene act upon podocytes other ways. Deeper probing APOL1-HIV interactions yield insights will aid understanding HIVAN, nephropathy, biology.

参考文章(32)
Patrick D. Dummer, Sophie Limou, Avi Z. Rosenberg, Jurgen Heymann, George Nelson, Cheryl A. Winkler, Jeffrey B. Kopp, APOL1 Kidney Disease Risk Variants: An Evolving Landscape Seminars in Nephrology. ,vol. 35, pp. 222- 236 ,(2015) , 10.1016/J.SEMNEPHROL.2015.04.008
Tomas Doyle, Caroline Goujon, Michael H. Malim, HIV-1 and interferons: who's interfering with whom? Nature Reviews Microbiology. ,vol. 13, pp. 403- 413 ,(2015) , 10.1038/NRMICRO3449
Nirupama Chandel, Bipin Sharma, Mohammad Husain, Divya Salhan, Tejinder Singh, Partab Rai, Peter W Mathieson, Moin A Saleem, Ashwani Malhotra, Pravin C Singhal, None, HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor. American Journal of Physiology-renal Physiology. ,vol. 304, ,(2013) , 10.1152/AJPRENAL.00717.2012
Juan C. Hernández, Mario Stevenson, Eicke Latz, Silvio Urcuqui-Inchima, HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro. AIDS Research and Human Retroviruses. ,vol. 28, pp. 1313- 1328 ,(2012) , 10.1089/AID.2011.0297
Michael S Lipkowitz, Barry I Freedman, Carl D Langefeld, Mary E Comeau, Donald W Bowden, WH Linda Kao, Brad C Astor, Erwin P Bottinger, Sudha K Iyengar, Paul E Klotman, Richard G Freedman, Weijia Zhang, Rulan S Parekh, Michael J Choi, George W Nelson, Cheryl A Winkler, Jeffrey B Kopp, AASK Investigators, Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans Kidney International. ,vol. 83, pp. 114- 120 ,(2013) , 10.1038/KI.2012.263
Siqin Zhaorigetu, Zhaoqing Yang, Ian Toma, Timothy A. McCaffrey, Chien-An A. Hu, Apolipoprotein L6, Induced in Atherosclerotic Lesions, Promotes Apoptosis and Blocks Beclin 1-dependent Autophagy in Atherosclerotic Cells Journal of Biological Chemistry. ,vol. 286, pp. 27389- 27398 ,(2011) , 10.1074/JBC.M110.210245
Stuart J. Shankland, Bart Smeets, Jeffrey W. Pippin, Marcus J. Moeller, The emergence of the glomerular parietal epithelial cell Nature Reviews Nephrology. ,vol. 10, pp. 158- 173 ,(2014) , 10.1038/NRNEPH.2014.1
L. Heggelund, F. Muller, E. Lien, A. Yndestad, T. Ueland, K. I. Kristiansen, T. Espevik, P. Aukrust, S. S. Froland, Increased Expression of Toll-Like Receptor 2 on Monocytes in HIV Infection: Possible Roles in Inflammation and Viral Replication Clinical Infectious Diseases. ,vol. 39, pp. 264- 269 ,(2004) , 10.1086/421780
Xiqian Lan, Aakash Jhaveri, Kang Cheng, Hongxiu Wen, Moin A. Saleem, Peter W. Mathieson, Joanna Mikulak, Sharon Aviram, Ashwani Malhotra, Karl Skorecki, Pravin C. Singhal, APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability American Journal of Physiology-renal Physiology. ,vol. 307, ,(2014) , 10.1152/AJPRENAL.00647.2013